Click here to visit Company website
Catalyst Pharmaceutical Partners, Inc., a development-stage specialty pharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.